Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Menopause affects hair and skin; more research needed for treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.